ESG Report 2019

Zhuhai Company was listed in the fourth batch of national green plant models issued by the Ministry of Industry and Information Technology The United Laboratories was awarded “2018 China Pharmaceutical Industry Top 100 Companies” by China National Pharm- aceutical Industry Information Center. 8 9 Insulin degludec injection of The United Laboratories was approved for clinical trial. 5 10 11 Zhuhai Company was awarded “2019 China Pharmaceutical Industry Top 100 Companies with Comprehensive Strength” (ranking the 18th) by China Pharmaceutical Industry Association. 12 “ Quality and Efficacy Evaluation research of Amoxicillin Capsule (0.25g) and Cefuroxime Axetil Tablet (0.25g)” was included in the 2019 Zhongshan Health Industry Development Special Project and received financial subsidies. Consistency of The Quality Control Center of passed the certification of China National Accreditation Service for Conformity Assessment (CNAS) for a second time. Zhuhai Company Zhuhai Company was awarded the " 2 0 1 9 Q u a l i t y I m p r o v e m e n t Excellence Project" and received the "2019 Outstanding Quality Manager Award"by the Guangdong Food and Drug Technology Association for Evaluation and Certification. The project of “Technology Development of New Drugs for Rheumatoid Arthritis Treatment” was selected as the fourth batch of Specially Technology Development Funds of 2019 and granted financial subsidies. Zhongshan in Environmental, Social and Governance Report 2019 The United Laboratories International Holdings Limited